ED Hypernatremia. Prognostic Factors and Epidemiology.

• Conditions: Hypernatremia

• Registration Number: NCT04265976
• Lead Sponsor: Centre Hospitalier Universitaire de Besancon

Brief Summary

This study evaluate the 1-month mortality of patients who proceed a blood sample while in the ED with an hypernatremia (\>145 mmol/l). This prospective study will try to show several prognostic factors, and show the epidemiology of hypernatremia in this single center evaluation.

Detailed Description

Not available

Study Timeline

• Study Start: 2019-08-26
• Status Verified: 2020-02
• Study First Submitted: 2020-02-10
• Study First Submitted QC: 2020-02-10
• Study First Posted: 2020-02-12
• Last Update Submitted: 2020-02-13
• Last Update Posted: 2020-02-17
• Primary Completion: 2020-05-26
• Study Completion: 2020-09-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 250

Inclusion Criteria

• Natremia > 145 mmol/l

Exclusion Criteria

• Age < 18 years
• Refusal

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
one month survival	1 month	Survival at 1 month after the blood sample at the ED

Trial Locations

Locations (1)

CHU Besançon; 🇫🇷 Besançon, France